Strafford will be offering a webinar entitled “Biotech Patents and Section 101 Rejections: Meeting Patent Eligibility Requirements — Leveraging Recent Decisions and USPTO Guidance to Overcome Rejections” on February 12, 2019 from 1:00 to 2:30 pm (EST). Amanda K. Murphy, Steven P. O’Connor, Sanya Sukduang, and Sara A. Leiman of Finnegan Henderson Farabow Garrett & Dunner will guide patent counsel for overcoming § 101 rejections for biotech patents, review recent case law and USPTO guidance on § 101 patent eligibility, and offer strategies to address § 101 rejections. The webinar will review the following issues: • The impact of the…
View the original article here: Webinar on Biotech Patents and Section 101 Rejections
The article was originally posted on Patent Docs.
Each article is copyrighted to their original authors. We do not own any rights to the news or the images used. Whilst every care is taken to ensure that the news posts published are accurate, we cannot guarantee the authenticity of the news article on every occasion. There’s no copyright infringement intended. The news is for informational purposes only and does not provide legal advice.